ReviewExpert review of anticancer therapy2015

ODM-201: a new-generation androgen receptor inhibitor in castration-resistant prostate cancer.

Karim Fizazi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.